Medicare for All Act

Bill Number: H.R. 3069
Origin Chamber: House
Congress: 119th Congress, Session 1
Policy Area: Health
Status: Introduced
Latest Action: 2025-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Last Updated: 2026-04-28T08:06:18Z

AI-Generated Summary

Purpose of the Legislation

The Medicare for All Act (H.R. 3069) aims to create a single-payer national health insurance system that provides universal, comprehensive health coverage to all U.S. residents. It seeks to replace the current mix of private insurance, employer plans, and public programs with a government-run program modeled on Medicare, eliminating out-of-pocket costs and profit motives in health care delivery to ensure equitable access and improve overall health outcomes.

Key Provisions

The bill is structured across 11 titles, establishing the program's framework, benefits, administration, funding, and transition.

Title I: Establishment, Coverage, and Enrollment
Creates the Medicare for All Program, entitling all U.S. residents (and potentially others) to benefits, with criteria for residency defined by the Secretary of Health and Human Services (HHS).
Guarantees freedom to choose qualified providers and prohibits discrimination based on race, age, disability, gender identity, sexual orientation, or other protected traits.
Mandates automatic enrollment at birth or residency establishment, issuing universal Medicare cards (without Social Security numbers).
Benefits start 2 years after enactment, with earlier access (1 year after) for those under 19 or over 55; prohibits duplicative private coverage.

Title II: Comprehensive Benefits
Covers a broad package of medically necessary services, including hospital care, primary/preventive services, mental health/substance use treatment, prescription drugs, reproductive care (including abortion and contraception), gender-affirming care, long-term services (prioritizing home- and community-based over institutional), vision, dental, and telehealth.
No deductibles, copays, or coinsurance; bans balance billing (providers charging patients extra) and prior authorizations (pre-approvals for care).
Excludes experimental treatments but allows appeals; Secretary must annually review and recommend benefit expansions (without eliminating any).
States may add benefits at their expense.

Title III: Provider Participation
Requires providers to meet state licensing, federal standards, and sign participation agreements ensuring non-discrimination, no extra charges, and ethical duties (e.g., no financial incentives tied to patient volume).
Establishes minimum national quality standards (e.g., staffing ratios, facility adequacy); whistleblower protections for reporting violations.
Allows private contracts for non-covered services but restricts them for covered ones to prevent opting out of the system.

Title IV: Administration
HHS Secretary oversees operations, including eligibility, payments, and regulations; establishes regional offices for needs assessments and quality assurance.
Includes a beneficiary ombudsman for complaints and applies fraud penalties from existing Medicare law.
Requires uniform data reporting on costs, quality, and equity; annual reports to Congress on program status.

Title V: Quality Assessment
Sets national standards via the Center for Clinical Standards and Quality, evaluating guidelines and measures (prohibiting discrimination against disabled people in assessments).
Mandates data collection on health disparities (by race, ethnicity, disability, etc.) and reports to address them.

Title VI: Budgeting, Payments, and Cost Containment
Establishes an annual national health budget with components for operations, capital (e.g., facility upgrades), special projects (e.g., rural access), education, and reserves.
Pays institutional providers (e.g., hospitals) via negotiated global budgets (lump sums covering all care); individual providers via fee-for-service schedules.
Negotiates drug/device prices annually; allows competitive licensing if negotiations fail (permitting generic production with compensation to originators).
Creates Offices of Health Equity and Primary Care to track disparities and boost access in underserved areas.
Prohibits payments for marketing, profits, or incentives; caps executive compensation.

Title VII: Funding
Establishes the Universal Medicare Trust Fund, financed by appropriations equivalent to current health program spending (e.g., Medicare, Medicaid), plus taxes on duplicative benefits.
Transfers remaining funds from existing Medicare trust funds; no restrictions on reproductive services.

Title VIII: ERISA Amendments
Prohibits employer plans from duplicating benefits; requires workers' compensation to reimburse the program.

Title IX: Conforming Changes
Integrates or sunsets existing programs: ends Medicare/Medicaid/SCHIP/ACA exchanges after 2 years (with transition for ongoing care); preserves VA/IHS benefits.
Terminates pay-for-performance and value-based programs.

Title X: Transition
Phased rollout over 2 years: immediate Medicare expansion to under-19s and over-55s; eliminates 24-month disability wait.
Offers a 1-year "buy-in" via ACA exchanges with subsidies, using Medicare rates; ensures continuity of care, especially for those with disabilities/chronic conditions.

Title XI: Miscellaneous
Defines terms (e.g., "medically necessary" as care deemed appropriate by providers under state/federal standards).
Allows states to add protections if they enhance access; prohibits using program resources for immigration enforcement.

Significant Changes to Existing Law

Overhaul of Health Coverage: Replaces fragmented systems (private insurance, ACA marketplaces, Medicaid) with a unified single-payer model, sunsetting ACA Exchanges, Medicare Advantage, and value-based incentives; integrates Medicaid/SCHIP into the program while preserving school-based services.
Elimination of Costs and Barriers: Ends all cost-sharing (unlike current Medicare's premiums/deductibles) and waiting periods for disabilities; bans profit-driven payments and private duplicative coverage.
Provider and Payment Reforms: Shifts to global budgets (vs. fee-for-service dominance) and direct drug negotiations (expanding on Medicare Part D); prohibits private contracts for covered care by participating providers.
Equity Focus: Mandates disparity tracking and offices for equity/primary care, building on but surpassing ACA nondiscrimination rules.

Potential Impacts

On Citizens: Provides free, universal access to comprehensive care, potentially reducing medical debt and improving health equity, but may increase taxes; disrupts current insurance, requiring transition support for 5 years (e.g., job training for affected workers).
On Government Agencies: Centralizes administration under HHS with regional offices, shifting burdens from states/insurers; requires new budgeting and data systems, with audits every 5 years; preserves VA/IHS but ends separate Medicaid funding.
On International Relations: Drug price negotiations and competitive licensing could pressure global pharmaceutical markets, potentially lowering U.S. prices to OECD averages; no direct foreign policy changes, but may influence health aid discussions.

Main Stakeholders Affected

U.S. Residents and Citizens: Primary beneficiaries, gaining universal coverage; vulnerable groups (e.g., low-income, disabled, rural) see prioritized access and disparity reductions.
Health Care Providers: Hospitals and doctors must adapt to global budgets and standards; incentives for primary care/rural staffing, but restrictions on profits/private practice.
Private Insurers and Employers: Phased out for duplicative coverage; employers lose health benefits role, shifting to wages or supplemental plans.
Pharmaceutical and Device Manufacturers: Face mandatory price negotiations and licensing, reducing profits but ensuring supply.
Government Entities: HHS gains expanded role; states retain licensing but lose Medicaid funding; tribes/VA/IHS continue independently.
Workers in Health Administration: Potential job losses in insurance, offset by transition aid and new equity/primary care roles.

Notable Legal, Constitutional, or Political Implications

Legal: Strengthens nondiscrimination (incorporating ACA Section 1557 and civil rights laws) with private lawsuits for violations; whistleblower protections mirror labor laws. Challenges may arise over drug licensing (patent takings) or ERISA preemptions for employer plans.
Constitutional: Expands federal commerce power over health care (like ACA), but could face Tenth Amendment suits from states on Medicaid sunset; ensures no immigration enforcement use, aligning with privacy rights.
Political: Represents a major shift to single-payer, potentially reducing administrative costs (currently ~30% of U.S. health spending) but sparking debates on taxes, innovation, and federal overreach; requires congressional hearings on benefits and broad consultations, emphasizing bipartisanship in implementation.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Jayapal, Pramila [D-WA-7]

Cosponsors (114)

Rep. Dingell, Debbie [D-MI-6], Rep. Adams, Alma S. [D-NC-12], Rep. Ansari, Yassamin [D-AZ-3], Rep. Balint, Becca [D-VT-At Large], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Bell, Wesley [D-MO-1], Rep. Beyer, Donald S. [D-VA-8], Rep. Bonamici, Suzanne [D-OR-1], Rep. Boyle, Brendan F. [D-PA-2], Rep. Brown, Shontel M. [D-OH-11], Rep. Carbajal, Salud O. [D-CA-24], Rep. Carson, André [D-IN-7], Rep. Carter, Troy A. [D-LA-2], Rep. Casar, Greg [D-TX-35], Rep. Cherfilus-McCormick, Sheila [D-FL-20], Rep. Chu, Judy [D-CA-28], Rep. Clarke, Yvette D. [D-NY-9], Rep. Cleaver, Emanuel [D-MO-5], Rep. Cohen, Steve [D-TN-9], Rep. Crockett, Jasmine [D-TX-30], Rep. Davis, Danny K. [D-IL-7], Rep. DeGette, Diana [D-CO-1], Rep. Deluzio, Christopher R. [D-PA-17], Rep. DeSaulnier, Mark [D-CA-10], Rep. Dexter, Maxine [D-OR-3], Rep. Doggett, Lloyd [D-TX-37], Rep. Escobar, Veronica [D-TX-16], Rep. Espaillat, Adriano [D-NY-13], Rep. Foushee, Valerie P. [D-NC-4], Rep. Frankel, Lois [D-FL-22], Rep. Friedman, Laura [D-CA-30], Rep. Frost, Maxwell [D-FL-10], Rep. Garamendi, John [D-CA-8], Rep. Garcia, Robert [D-CA-42], Rep. García, Jesús G. "Chuy" [D-IL-4], Rep. Goldman, Daniel S. [D-NY-10], Rep. Gomez, Jimmy [D-CA-34], Rep. Green, Al [D-TX-9], Rep. Hayes, Jahana [D-CT-5], Rep. Hoyle, Val T. [D-OR-4], Rep. Huffman, Jared [D-CA-2], Rep. Jackson, Jonathan L. [D-IL-1], Rep. Jacobs, Sara [D-CA-51], Rep. Johnson, Henry C. "Hank" [D-GA-4], Rep. Kamlager-Dove, Sydney [D-CA-37], Rep. Keating, William R. [D-MA-9], Rep. Kelly, Robin L. [D-IL-2], Rep. Kennedy, Timothy M. [D-NY-26], Rep. Khanna, Ro [D-CA-17], Rep. Lee, Summer L. [D-PA-12] and 64 more

Recent Actions

2025-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-04-29: Introduced in House
2025-04-29: Introduced in House

Bill Versions

Medicare for All Act — issued 2025-04-29 — PDF (132 pages)